News & Articles

Advancing early Alzheimer's diagnosis with scalable, ultra-sensitive technology

Nucleus Biologics has received EXCiPACT certification for pharmaceutical excipients and pharmaceutical auxiliary materials (PAMs) and ISO 9001 certification from SGS

With over 40 years of biopharma leadership experience, Dr. Slaoui will help drive innovation and growth for Abzena

Researchers at MedAustron Ion Therapy Center and Karl Landsteiner University of Health Sciences improve methods for energy deposition into tumour tissue

AI-powered solution to enhance diagnostic efficiency, streamline clinical trials, and improve patient outcomes across global pathology networks

NuAire has joined the Kewaunee Scientific Corporation family of companies to work together to produce equipment for your laboratory

Preclinical study demonstrates the potential of mRNA-encoded immune modulators delivered via lipid nanoparticles to enhance anti-tumor immunity and overcome immunotherapy resistance

Scripps Research scientists reveal microgravity’s effects on brain cells

This partnership grants CNX the exclusive rights to market Nitrofurantoin in 27 countries, including key markets such as the UK, France, Germany and Italy

evitria, has selected Sapio to enhance its sample tracking, data capture, and reporting capabilities in antibody workflows

Newly built 45,000 sq ft facility houses engineering and skilled manufacturing employees at Longbridge Business Park, a specialized hub for science and technology

The large state-of-the-art facility in Orem, Utah, allows KPM Analytics to expand its Artificial Intelligence and software development utilized across KPM’s brand portfolio

Experts from Chan Zuckerberg Initiative, FDA, AbbVie, Elsevier, Penn Medicine, Takeda and others discuss patient-centricity, data standards, and copyright

Tropical Fever Panel a syndromic PCR test, targets the causes of tropical fever infections

The study was commissioned and funded by the National Institute for Health and Care Research (NIHR), and its leading partners were The University of Manchester, Northern Care Alliance NHS Foundation Trust and Warwick Medical School’s Clinical Trials Unit, who specialize in research in emergency and critical care

T2 Biosystems announces plans to license its proprietary technology to accelerate the broad adoption of direct-from-whole-blood diagnostics, generate non-dilutive capital, and create a new royalty revenue stream

Series A financing highlights the potential impact of Abselion’s technology for life science research and bioprocess development

Research at Karl Landsteiner University of Health Sciences offers new insight in brain connectivity and development

The PATHWAY HER2 (4B5) test helps identify patients with previously treated, unresectable or metastatic HER2-positive biliary tract cancer (BTC) who may be eligible for treatment with ZIIHERA

The expansion enhances Abzena’s extensive bioassay offering, providing customers with a more comprehensive, streamlined, and cost-effective way to access critical data faster

Collaboration to advance newborn genetic screening, leveraging cutting-edge genomics research and laboratory expertise to detect rare conditions early